Eric W Alton

Title: The Innovations of Eric W Alton

Introduction

Eric W Alton is a notable inventor based in London, GB. He has made significant contributions to the field of gene therapy, particularly in the treatment of genetic respiratory diseases. His innovative approaches have the potential to transform the way such diseases are treated.

Latest Patents

Eric W Alton holds a patent for a groundbreaking method titled "Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein." This patent describes a technique where genes are successfully introduced into stem cells of airway epithelial tissues using simian immunodeficiency virus vectors pseudotyped with F and HN, which are envelope glycoproteins of Sendai virus. This method is particularly useful for gene therapy of genetic respiratory diseases such as cystic fibrosis. Additionally, it allows for the selection of respiratory organs, such as the lungs, as production tissues for providing proteins that are deficient due to genetic diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Eric has worked with various companies, including Id Pharma Co., Ltd. and IP Pharma Co., Ltd. His work in these organizations has furthered the development of innovative therapies and technologies in the field of gene therapy.

Collaborations

Eric has collaborated with notable individuals in his field, including Katsuyuki Mitomo and Makoto Inoue. These collaborations have contributed to the advancement of research and development in gene therapy.

Conclusion

Eric W Alton's contributions to gene therapy and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of genetic respiratory diseases, paving the way for future innovations in the field.